PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\', \'Abadan School of Medical Sciences, Abadan, Iran.\', \'Immunology Today, Universal Scientific Education and Research Network (USERN), Tehran, Iran.\', \'Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\', \'Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\', \'Infectious Diseases & Tropical Medicine Ward, Razi Teaching Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/08923973.2021.1925293
?:doi
?:hasPublicationType
?:journal
  • Immunopharmacology and immunotoxicology
is ?:pmid of
?:pmid
?:pmid
  • 34015982
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.711
?:rankingScore_hIndex
  • 41
is ?:relation_isRelatedTo_publication of
?:title
  • Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all